Rich Statham

Rich Statham has over 30 years of work experience in the pharmaceutical industry. Rich has held several leadership roles in various companies, including Eisai EMEA, Otsuka Pharmaceutical Companies Europe, Janssen Europe, Middle East & Africa (EMEA), The Janssen Pharmaceutical Companies of Johnson & Johnson, Bayer, and Servier.

Rich'smost recent position was as the Vice President, EMEA Dementia Franchise Lead at Eisai EMEA. Prior to that, they served as the EMEA Alzheimer's Disease Ecosystem Platform Leader.

Before joining Eisai EMEA, Rich Statham worked at Otsuka Pharmaceutical Companies Europe as the EMEA Vice President - Specialty and Oncology Business Lead, where they were responsible for setting the strategic direction and managing resources for sustainable long-term company growth in the specialty and oncology sectors.

Earlier in their career, they held various roles at Janssen Europe, Middle East & Africa (EMEA), including Change Management Director, Regional Strategic Marketing & Commercial Director for Oncology and Haematology, and Cross Regional Brand Lead for Anaemia.

Prior to joining Janssen, Rich Statham worked at The Janssen Pharmaceutical Companies of Johnson & Johnson in the UK and Ireland, where they held positions such as Sales & Marketing Manager, Group Product Manager, Regional Business Manager, and Product Manager.

Before entering the pharmaceutical industry, they began their career as a Sales Representative at Bayer and Servier.

Overall, Rich Statham has extensive experience in strategic leadership, commercial management, and sales in the pharmaceutical industry.

Rich Statham studied Podiatric Medicine at the University of Brighton from 1991 to 1994. Rich also obtained a Marketing Diploma from CIM | The Chartered Institute of Marketing. Rich attended Duston Upper School in Northampton, but no degree or field of study was specified. Additionally, they earned a CIM Diploma in Marketing, but the institution, month, and year of completion are unknown.